Lung cancer trials in Belgium

In Belgium 127 Also abroad 2747

127 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Methylated Biomarkers of Smoking as a Selection Tool in Participants for Lung Cancer Screening
Where
Antwerp
Age
50 years and over
People
1,000
Run by
University Hospital, Antwerp
See details and how to joinNCT07631624
Phase 1/2Taking people
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
Where
Anderlecht, Edegem
Age
18 years and over
People
41 worldwide
Run by
OSE Immunotherapeutics
See details and how to joinNCT05751798 · EU 2024-514826-22-00
Phase 2Taking people
Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients
Where
Jette
Age
18 years and over
People
20
Run by
Universitair Ziekenhuis Brussel
See details and how to joinNCT05933239
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Leuven
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
Phase 3Taking people
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Where
Leuven
Age
18 years and over
People
180 worldwide
Run by
Nuvation Bio Inc.
See details and how to joinNCT07154706 · EU 2025-521971-29-00
Phase 1Taking people
Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
Where
Anderlecht
Age
18 years and over
People
76 worldwide
Run by
Novartis Pharma AG
See details and how to join2023-510356-23-00
Phase 3Taking people
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
Where
Brussels, Edegem, Liège
Age
18 years and over
People
170 worldwide
Run by
Grupo Espanol de Tumores Neuroendocrinos
See details and how to joinNCT05918302 · EU 2022-502154-13-00
Phase 2/3Taking people
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Adult Participants with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Where
Hasselt, Leuven, Liège, Roeselare
Age
18 years and over
People
50 worldwide
Run by
AbbVie Deutschland GmbH & Co. KG
See details and how to join2024-518586-10-00
Phase 1Taking people
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Where
Edegem
Age
18 years and over
People
304 worldwide
Run by
AstraZeneca
See details and how to joinNCT04686305 · EU 2023-504949-31-00
Phase 1Taking people
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
Where
Brussels, Edegem, Ghent, Leuven
Age
18 years and over
People
55 worldwide
Run by
DeuterOncology
See details and how to joinNCT05752552
Phase 4Taking people
Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI-SAVE
Where
Anderlecht, Bruxelles, Charleroi, Edegem, Gent, Jette, Leuven, Mons, Roeselare, Yvoir
Age
18 years and over
People
283 worldwide
Run by
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2024-514693-47-01
No phaseTaking people
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Where
Brussels
Age
18 years and over
People
8,000 worldwide
Run by
UMC Utrecht
See details and how to joinNCT04075305
Phase 2/3Not yet taking people in Belgium
Pre- and post-treatment evaluation of lung function with Xenon-gas enhanced Dual-Energy CT-imaging in patients undergoing radiotherapy
Where
Jette
Age
18 years and over
People
40
Run by
UZ Brussel
See details and how to join2025-521559-22-00
No phaseTaking people
Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease
Where
Brussels
Age
Up to 80 years
People
425
Run by
Université Catholique de Louvain
See details and how to joinNCT07384897
No phaseTaking people
Physical Activity Coaching After Surgery for Patients With Resectable Non-small Cell Lung Cancer
Where
Bruges, Genk, Ghent, Hasselt, Roeselare
Age
18 years and over
People
90
Run by
University Hospital, Ghent
See details and how to joinNCT06057766
Phase 1Not yet taking people in Belgium
A phase 1b study of an autologous dendritic cell immunotherapy in combination with anti-programmed death-1 treatment in patients with metastatic non-small-cell lung cancer (DARE-LUNG)
Where
Gent
Age
18 years and over
People
64
Run by
Universitair Ziekenhuis Gent
See details and how to join2025-521577-13-00
Phase 2Taking people
Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)
Where
Hasselt
Age
18 years and over
People
20 worldwide
Run by
University Hospital, Essen
See details and how to joinNCT06784791 · EU 2023-505662-28-00
No phaseTaking people
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
Where
Genk
People
350
Run by
Hasselt University
See details and how to joinNCT07087080
Phase 1/2Taking people
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
Where
Anderlecht
Age
18 years and over
People
140 worldwide
Run by
Pierre Fabre Medicament
See details and how to joinNCT06669117 · EU 2024-512760-64-00
Phase 3Taking people
Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study
Where
Aalst, Anderlecht, Charleroi, Hasselt, Jette, La Louvière, Liège, Montigny-Le-Tilleul, Namur, Roeselare, Sint-Lambrechts-Woluwe, Yvoir
Age
18 years and over
People
1,166 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05692999 · EU 2023-503481-23-00
No phaseTaking people
Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
Where
Brussels
Age
18 years and over
People
58
Run by
Jules Bordet Institute
See details and how to joinNCT06107608
Phase 1/2Taking people
Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer
Where
Brussels, Charleroi, Jolimont, Kortrijk, Liège, Mons, Roeselare
Age
18 years and over
People
32 worldwide
Run by
Inhatarget Therapeutics
See details and how to joinNCT06896890
No phaseTaking people
Cardiopulmonary Toxicity of Thoracic Radiotherapy
Where
Leuven
Age
18 years and over
People
320 worldwide
Run by
University Medical Center Groningen
See details and how to joinNCT03978377
No phaseTaking people
Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study
Where
Ghent
Age
18 years and over
People
40
Run by
University Hospital, Ghent
See details and how to joinNCT05693363
No phaseNot yet taking people in Belgium
Understanding Lung Cancer Related Risk Factors and Their Impact
Where
Liège
Age
40 years to 80 years
People
6,160 worldwide
Run by
Biobizkaia Health Research Institute
See details and how to joinNCT06473870